TSS
ABVC icon

Two Sigma Securities’s ABVC BioPharma ABVC Stock Holding History

Two Sigma Securities’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4K Buy
+21,023
New +$34.8K ﹤0.01% 1370
2025
Q2 		– Sell
-11,470
Closed -$12.2K – 1442
2025
Q1 		$12.2K Sell
11,470
-1,123
-9% -$682 ﹤0.01% 1196
2024
Q4 		$7.43K Buy
12,593
+196
+2% +$109 ﹤0.01% 1460
2024
Q3 		$8.47K Buy
+12,397
New +$8.95K ﹤0.01% 2619
2023
Q2 		– Sell
-2,107
Closed -$13.5K – 2725
2023
Q1 		$13.5K Buy
+2,107
New +$15.1K ﹤0.01% 2414

Other funds holding ABVC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's ABVC Position: Q1 2026 in Review

Two Sigma Securities opened a new position in ABVC BioPharma (ABVC) in Q1 2026: 21,023 shares worth $20.4K. The stake represents ﹤0.01% of the portfolio and ranks #1370 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ABVC as recently as Q1 2025.

Two Sigma Securities first reported a position in ABVC in Q1 2023 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold ABVC as of Q1 2026.

  • Two Sigma Securities held 21,023 shares of ABVC BioPharma worth $20.4K as of Q1 2026.
  • ABVC BioPharma was a new Two Sigma Securities position in Q1 2026.
  • ABVC BioPharma made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1370 holding.
  • Two Sigma Securities first reported a position in ABVC BioPharma in Q1 2023 and has held it in 5 quarters since.
  • 13 funds tracked by Wall St. Rank held ABVC BioPharma as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.